HOUSTON--(BUSINESS WIRE)--ThromboVision, Inc., a Houston-based biomedical diagnostics company, has completed a $4 million Series A convertible preferred stock financing, led by private equity firm National Healthcare Services and a group of private investors. The offering was oversubscribed.
